Erste Asset Management Gmb H Beam Therapeutics Inc. Transaction History
Erste Asset Management Gmb H
- $11.9 Trillion
- Q2 2025
A detailed history of Erste Asset Management Gmb H transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Erste Asset Management Gmb H holds 21,700 shares of BEAM stock, worth $585,900. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,700
Previous 21,700
-0.0%
Holding current value
$585,900
Previous $482 Million
24.36%
% of portfolio
0.0%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding BEAM
# of Institutions
246Shares Held
95.7MCall Options Held
666KPut Options Held
1.99M-
Farallon Capital Management LLC San Francisco, CA10MShares$270 Million0.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.71MShares$262 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.85MShares$239 Million1.24% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$206 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.4.73MShares$128 Million0.05% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.9B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...